CANCERVOL. 88, NO.1; 1 JANUARY, 2000
EDITORIALCANCER launches Accelerated Publication: a message from the Editor –in - ChiefRobert V. P. Hutter
1
COMMENTARYThe new millennium: Applying novel technology to the study of thecancer cell in situMonica R. Brown, Elise C. Kohn, Robert V. P. Hutter
2-5
REVIEW ARTICLEOral bisphosphonates: A review of clinical use in patients with bonemetastasesPierre P. Major, Allan Lipton, James Berenson, Gabriel Hortobagyi
6-14
ORIGINAL ARTICLEANATOMIC SITESALIVARY GLAND ( C08.9)Kaposi sarcoma of major salivary gland origin: A clinicopathologic seriesof six casesJames T. Castle, Lester D. R. Thompson
15-23
STOMACH (C16.9)Fhit expression in gastric adenocarcinoma: Correlation with disease stageand survivalDavid Capuzzi, Emanuele Santoro, Walter W. Hauck, Albert J. Kovatich,Francis E. Rosato, Raffaele Baffa, Kay Huebner, Peter A. McCue
24-34
COLON AND RECTUM (C19.9)Time-dependency of the prognostic effect of carcinoembryonic antigenand p53 protein in colorectal adenocarcinomaManuel Díez, Marina Pollán, Jose M. Müguerza, Maria J. Gaspar, AntonioM. Duce, María J. Alvarez, Tomás Ratia, Pilar Hernández, Antonio Ruiz,Javier Granell
35-41
Expression of platelet-derived endothelial cell growth factor correlateswith good prognosis in patients with colorectal carcinomaShinsuke Saito, Nelson Tsuno, Hirokazu Nagawa, Eiji Sunami, JinZhengxi, Takuya Osada, Joji Kitayama, Yoichi Shibata, Takashi Tsuruo,Tetsuichiro Muto
42-49
LIVER (C22.0)A prognostic index of the survival of patients with unresectablehepatocellular carcinoma after transcatheter arterial chemoembolizationLaura Lladó, Joan Virgili, Joan Figueras, Carles Valls, Joan Dominguez,Antoni Rafecas, Jaume Torras, Joan Fabregat, Jordi Guardiola, EduardoJaurrieta
50-57
The effect of retreatment with interferon- α on the incidence ofhepatocellular carcinoma in patients with chronic hepatitis CHidenori Toyoda, Takashi Kumada, Satoshi Nakano, Isao Takeda, KeiichiSugiyama, Seiki Kiriyama, Yasuhiro Sone, Yasuhiro Hisanaga
58-65
GASTROINTESTINAL TRACT (C26.9)Salvage surgery for patients with recurrent gastrointestinal sarcoma:Prognostic factors to guide patient selectionSatvinder S. Mudan, Kevin C. Conlon, James M. Woodruff, Jonathan J.Lewis, Murray F. Brennan
66-74
BLOOD/BONE MARROW (C42.1)Increased CA 125 serum levels in patients with advanced acute leukemiawith serosal involvementAndrea Camera, Maria Rosaria Villa, Stefano Rocco, Tiziana De Novellis,Silvia Costantini, Luca Pezzullo, Anna Lucania, Angela Mariano,Vincenzo Macchia, Bruno Rotoli
75-78
SKIN (C44.9)Paclitaxel and tamoxifen: An active regimen for patients with metastaticmelanomaFaith E. Nathan, David Berd, Takami Sato, Michael J. Mastrangelo
79-87
Locally advanced melanoma: Results of postoperative hypofractionatedradiation therapyGraham Stevens, John F. Thompson, Ian Firth, Christopher J. O'Brien,William H. McCarthy, Michael J. Quinn
88-94
BREAST (C50.9)Outcome of patients with metastatic breast carcinoma treated at a privatemedical oncology clinicWilliam F. Anderson, James E. Reeves, Abdalla Elias, Hans (J) Berkel
95-107
A high number of tumor free axillary lymph nodes from patients withlymph node negative breast carcinoma is associated with poor outcomeRobert L. Camp, Eric B. Rimm, David L. Rimm
108-113
Racial differences in breast carcinoma survivalSue A. Joslyn, Michele M. West
114-123
A Phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinomaEdith A. Perez, David W. Hillman, Philip J. Stella, James E. Krook, LynnC. Hartmann, Tom R. Fitch, Alan K. Hatfield, James A. Mailliard, SureshNair, Carl G. Kardinal, James N. Ingle
124-131
CERVIX (53.9)Bax and Bcl-2 protein expression following radiation therapy versusradiation plus thermoradiotherapy in Stage IIIB cervical carcinomaYoko Harima, Kenji Nagata, Keizo Harima, Atsutoshi Oka, Valentina V.Ostapenko, Nobuaki Shikata, Takeo Ohnishi, Yoshimasa Tanaka
132-138
ENDOMETRIUM (C.54.1)Does hysteroscopy facilitate tumor cell dissemination?: Incidence ofperitoneal cytology from patients with early stage endometrial carcinomafollowing dilatation and curettage (D & C) versus hysteroscopy and D & CAndreas Obermair, Magda Geramou, Fatih Gucer, Ursula Denison, AntonH. Graf, Elisabeth Kapshammer, Walter Neunteufel, Inge Frech,Alexandra Kaider, Christian Kainz
139-143
OVARY (56.9)The role of secondary cytoreductive surgery in the treatment of patientswith recurrent epithelial ovarian carcinomaScott M. Eisenkop, Richard L. Friedman, Nick M. Spirtos
144-153
TESTIS (C62.9)Testicular lymphoma is associated with a high incidence of extranodalrecurrenceRafael Fonseca, Thomas M. Habermann, Joseph P. Colgan, Brian P.O'Neill, William L. White, Thomas E. Witzig, Kathleen S. Egan, James A.Martenson, Lawrence J. Burgart, David J. Inwards
154-161
Tumor markers at the time of recurrence in patients with germ cell tumorsJosé M. Trigo, José M. Tabernero, Luis Paz-Ares, José L. García-Llano,José Mora, Pilar Lianes, Emilio Esteban, Ramón Salazar, Juan J. López-López, Hernán Cortés-Funes
162-168
NERVOUS SYSTEM NOS (C72.9)Chemotherapy in patients with recurrent and progressive centralneurocytomaAlba A. Brandes, Pietro Amistà, Marina Gardiman, Lorenzo Volpin,Daniela Danieli, Bianca Guglielmi, Carla Carollo, Gianpietro Pinna,Sergio Turazzi, Silvio Monfardini
169-174
LYMPH NODE (C77.9)Lymph node metastases: The importance of the microenvironmentAlessandro D. Santin
175-179
GENERAL TOPICCHEMOTHERAPY: SOLID TUMOR METASTASESA Phase I study of gemcitabine and docetaxel in patients with metastaticsolid tumorsDavid P. Ryan, Thomas J. Lynch, Michael L. Grossbard, Michael V.Seiden, Charles S. Fuchs, Nina Grenon, Paul Baccala, Deborah Berg,Dianne Finkelstein, Robert J. Mayer, Jeffrey W. Clark
180-185
PEDIATRIC ONCOLOGYLarge cell non-Hodgkin lymphoma of childhood: Analysis of 78consecutive patients enrolled in 2 consecutive protocols at the MemorialSloan-Kettering Cancer CenterJaume Mora, Daniel A. Filippa, Howard T. Thaler, Tatyana Polyak,Milicent L. Cranor, Norma Wollner
186-197
Hemangiopericytoma in children and infantsCarlos Rodriguez-Galindo, Kirk Ramsey, Jesse J. Jenkins, Catherine A.Poquette, Sue C. Kaste, Thomas E. Merchant, Bhaskar N. Rao, Charles B.Pratt, Alberto S. Pappo
198-204
Effective preventive central nervous system therapy with extended tripleintrathecal therapy and the modified ALL-BFM 86 chemotherapy programin an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: The Israel National Study reportBatia Stark, Rivka Sharon, Gideon Rechavi, Dina Attias, Ami Ballin,Gabriel Cividalli, Yoav Burstein, Dalia Sthoeger, Ayala Abramov, Rina
205-216
ZaizovQUALITY OF LIFEEvaluation of an instrument to assess the needs of patients with cancerBillie Bonevski, Rob Sanson-Fisher, Afaf Girgis, Louise Burton, PeterCook, Allison Boyes
217-225
The unmet supportive care needs of patients with cancerRob Sanson-Fisher, Afaf Girgis, Allison Boyes, Billie Bonevski, LouiseBurton, Peter Cook
226-237
CORRESPONDENCEThe prognostic significance of amplification and overexpression of c-metand c-erb B-2 in human gastric carcinomasFátima Carneiro, Manuel Sobrinho-Simões
238-239
Author replyMasakazu Nakajima
239-240
Extramedullary plasmacytoma: Tumor occurrence and therapeuticconceptsNilüfer Güler
240-241
Author replyChristoph Alexiou, Wolfgang Arnold
241-242
Pathologic findings from the national surgical adjuvant breast project(NSABP) eight-year update of protocol B-17Melvin J. Silverstein, Michael D. Lagios
242-243
Author replyEdwin R. Fisher
243-244
VOL. 88, NO. 2; 15 JANUARY 2000ORIGINAL ARTICLEANATOMIC SITEORAL CAVITY (C06.9)Immunohistochemical study of MUC1 mucin in premalignant oral lesionsand oral squamous cell carcinoma: Association with disease progression,mode of invasion, and lymph node metastasisTetsuya Nitta, Kazumasa Sugihara, Shinichro Tsuyama, Fusayoshi Murata
245-254
NASOPHARYNX ( C11.9)Elevation of serum vascular endothelial growth factor in male patientswith metastatic nasopharyngeal carcinomaChao-Nan Qian, Chang-Qing Zhang, Xiang Guo, Ming-Huang Hong, Su-Mei Cao,Wei-Yuan Mai, Hua-Qing Min, Yi-Xin Zeng
255-261
ESOPHAGUS (C15.9)Small cell carcinoma of the esophagus: The University of Texas M. D.Anderson Cancer Center Experience and Literature ReviewDiana C. Medgyesy, Robert A. Wolff, Joe B. Putnam Jr., Jaffer A. Ajani
262-267
Gains of 8q23-qter and 20q and loss of 11q22-qter in esophagealsquamous cell carcinoma associated with lymph node metastasisKohsuke Tada, Masaaki Oka, Akira Tangoku, Hiroto Hayashi, AtsunoriOga, Kohsuke Sasaki
268-273
STOMACH ( C16.9)Individual and joint contribution of family history and Helicobacter pyloriinfection to the risk of gastric carcinomaHermann Brenner, Volker Arndt, Til Stürmer, Christa Stegmaier, HartwigZiegler, Georg Dhom
274-279
Detection of circulating gastric carcinoma-associated antigen MG7-Ag inhuman sera using an established single determinant immuno-polymerasechain reaction techniqueJun Ren, Zheng Chen, Shao Juan Zhou, Xue Yong Zhang, Bo Rong Pan,Dai Ming Fan
280-285
SMALL INTESTINE (C17.9)A clinicopathologic study of primary small intestine lymphoma:Prognostic significance of mucosa-associated lymphoid tissue-derivedlymphomaShotaro Nakamura, Takayuki Matsumoto, Morishige Takeshita, KoichiKurahara, Takashi Yao, Masazumi Tsuneyoshi, Mitsuo Iida, MasatoshiFujishima
286-294
COLON AND RECTUM ( C19.9)Tissue factor expression in human colorectal carcinoma: Correlation withhepatic metastasis and impact on prognosisShin-ichi Seto, Hisashi Onodera, Toshimi Kaido, Akira Yoshikawa, Shun-ichi Ishigami, Shigeki Arii, Masayuki Imamura
295-301
LIVER (C22.0)Percutaneous microwave coagulation therapy for patients with primary andmetastatic hepatic tumors during interruption of hepatic blood flowTakashi Shibata, Takamichi Murakami, Norio Ogata
302-311
Precancerous hepatic nodules had significant levels of telomerase activitydetermined by sensitive quantitation using a hybridization protection assayHideki Takaishi, Mikiya Kitamoto, Shoichi Takahashi, Hiroshi Aikata,Yoshiiku Kawakami, Toshio Nakanishi, Yasuhiro Nakamura, FumioShimamoto, Goro Kajiyama, Toshinori Ide
312-317
LUNG (C34.9)UFT plus cisplatin combination chemotherapy in the treatment of patientswith advanced nonsmall cell lung carcinoma: A multiinstitutional Phase IItrialYukito Ichinose, Kozo Yosimori, Shuichi Yoneda, Mutsuo Kuba, ShojiKudoh, Hisanobu Niitani
318-323
BONE (C41.9)Osteosarcomas of flat bones in adolescents and adultsFlorence Duffaud, Laurence Digue, Marjorie Baciuchka-Palmaro,Françoise Volot, Catherine Perles-Daniel, Louise Garbe, Roger Favre
324-332
BLOOD/BONE MARROW (C42.1)Plasma FLT3-L levels predict bone marrow recovery frommyelosuppressive therapyRosalyn D. Blumenthal, Walter Lew, Malik Juweid, Rita Alisauskas,Zhiliang Ying, David M. Goldenberg
333-343
Derivation of a new hematopoietic cell line with endothelial features froma patient with transformed myeloproliferative syndrome: A case reportWalter Fiedler, R. Peter Henke, Süleyman Ergün, Udo Schumacher,Ursula M. Gehling, Gabi Vohwinkel, Nerbil Kilic, Dieter K. Hossfeld
344-351
Deoxycoformycin in the treatment of patients with hairy cell leukemia:Results of a Spanish collaborative study of 80 patientsMontserrat Rafel, Francisco Cervantes, José María Beltrán, FranciscoZuazu, Luis Hernández Nieto, Consuelo Rayón, Juan García Talavera,Emilio Montserrat
352-357
PERITONEUM (C48.2)Peritoneal carcinomatosis from non-gynecologic malignancies: Results ofthe EVOCAPE 1 multicentric prospective studyBabak Sadeghi, Catherine Arvieux, Olivier Glehen, Annie C. Beaujard,Michel Rivoire, Jacques Baulieux, Eric Fontaumard, Alain Brachet, JeanL. Caillot, Jean L. Faure, Jack Porcheron, Jean L. Peix, Yves François,Jacques Vignal, François N. Gilly
358-363
SOFT TISSUE (C49.9)Metastases to the retroperitoneum in patients with extremity soft tissuesarcoma: An unusual metastatic patternDina Lev-Chelouche, Richard Nakache, Dror Soffer, Ofer Merimsky,Joseph M.Klausner, Mordechai Gutman
364-368
BREAST (C50.9)Age-related variation in the treatment and outcomes of patients with breastcarcinomaJonathan Golledge, Joan E. Wiggins, Michael J. Callam
369-374
A phase II trial of high dose epirubicin in patients with advanced breastcarcinomaKathy D. Miller, Nikhil Munshi, David Loesch, Lawrence H. Einhorn,George W. Sledge Jr.
375-380
OVARY (C56.9)Antitumor activity of a novel glyco-nitric oxide conjugate in ovariancarcinomaGuilherme Cantuaria, Albino Magalhaes, Roberto Angioli, Luis Mendez,Ramin Mirhashemi, Jianqiang Wang, Peng Wang, Manuel Penalver,Hervy Averette, Paul Braunschweiger
381-388
Primary cytoreductive surgery with rectosigmoid colon resection forpatients with advanced epithelial ovarian carcinomaCarlo Scarabelli, Angelo Gallo, Silvia Franceschi, Elio Campagnutta,Giovanni De Piero, Giorgio Giorda, Maria Caterina Visentin, AntoninoCarbone
389-397
PROSTATE (C61.9)Second malignancies in prostate carcinoma patients after radiotherapycompared with surgeryDavid J. Brenner, Rochelle E. Curtis, Eric J. Hall, Elaine Ron
398-406
Short term neoadjuvant androgen deprivation therapy does not affectprostate specific membrane antigen expression in prostate tissues
407-415
Sam S. Chang, Victor E. Reuter, W. D. W. Heston, Brian Hutchinson,Lana S. Grauer, Paul B. GaudinPrognostic significance of p16 and CDK4 proteins in localized prostatecarcinomaOle J. Halvorsen, Jens Høstmark, Svein Haukaas, Per Å. Høis æter, Lars A.Akslen
416-424
A comparison of external beam radiation therapy versus radicalprostatectomy for patients with low risk prostate carcinoma diagnosed,staged, and treated at a single institutionAlvaro A. Martinez, Jose A. Gonzalez, Andrew K. Chung, Larry L.Kestin, Mamtha Balasubramaniam, Ananias C. Diokno, Ellen L. Ziaja,Donald S. Brabbins, Frank A. Vicini
425-432
BRAIN (C71.9)Predominance of brain tumors in an extended Li-Fraumeni (SBLA)kindred, including a case of Sturge-Weber syndromeHenry T. Lynch, Rodney D. McComb, Neal K. Osborn, Paul A. Wolpert,Jane F. Lynch, Zbigniew K. Wszolek, David Sidransky, Robert E. Steg
433-439
A role for telomeric and centromeric instability in the progression ofchromosome aberrations in meningioma patientsJeffrey R. Sawyer, Muhammad Husain, Svetlana Pravdenkova, Ali Krisht,Ossama Al-Mefty
440-453
LYMPH NODE (C77.9)Short term treatment with Escheria coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for HodgkindiseaseM. Aglietta, F. Montemurro, F. Fagioli, C. Volta, B. Botto, M. Cantonetti,V. Racanelli, L. Teofili, R. Ferrara, S. Amadori, G. L. Castoldi, F.Dammacco, A. Levis
454-460
GENERAL TOPICGYNECOLOGIC CANCERThe tumor-associated shift in immunoglobulin G1/G2 is expressed at themessenger RNA level of peripheral blood B lymphocytes in patients withgynecologic malignanciesPeter Felsner, Waltraud Steinschifter, Michaela Fischer, Robert Eferl,Lukas Kenner, Kurt Zatloukal, Manfred Lahousen, Peter M. Liebmann,Erwin Schauenstein, Konrad Schauenstein
461-467
IMMUNOLOGY/IMMUNOTHERAPYOrthotopic human lung carcinoma xenografts in BALB/c miceimmunosuppressed with anti-CD4 monoclonal antibodies and chronicalcohol consumptionJay D. Hunt, Everett G. Robert, Arthur W. Zieske, Abraham P. Bautista,Mirjana Bukara, Dinghua Lei, Judd E. Shellito, Steve Nelson, Jay K.Kolls, Nebojsa Skrepnik
468-479
PEDIATRIC ONCOLOGYSplenic rupture in children with hematologic malignanciesUma H. Athale, Sue C. Kaste, Sara M. Bodner, Raul C. Ribeiro
480-490
VOL. 88, NO. 3; 1 FEBRUARY 2000EDITORIALMythology and numerology in the sphere of melanomaA. Bernard Ackerman
491-496
Secondary leukemia: Twice is a coincidence?Wallace Akerley
497-499
REVIEW ARTICLEClassic Kaposi sarcoma: Epidemiology and risk factorsJose Iscovich, Paolo Boffetta, Silvia Franceschi, Esther Azizi, Ronit Sarid
500-517
ORIGINAL ARTICLEANATOMIC SITESALIVARY GLAND ( C08.9)H-ras gene mutations in salivary gland mucoepidermoid carcinomasJinyoung Yoo, Robert A. Robinson
518-523
ESOPHAGUS (C15.9)Fas ligand expression in esophageal carcinomas and their lymph nodemetastasesMamoun Younes, Mary R. Schwartz, Atilla Ertan, Delia Finnie, AnasYounes
524-528
LIVER (C22.0)Predictive factors for intrahepatic recurrence after percutaneous ethanolinjection therapy for small hepatocellular carcinomaMasahiko Koda, Yoshikazu Murawaki, Akeri Mitsuda, Kenji Ohyama,Yutaka Horie, Takeaki Suou, Hironaka Kawasaki, Shiro Ikawa
529-537
Is the pathologic TNM staging system for patients with hepatomapredictive of outcome?J. Wallis Marsh, Igor Dvorchik, C. Andrew Bonham, Shunzaburo Iwatsuki
538-543
Serum levels of des-γ-carboxy prothrombin measured using the revisedenzyme immunoassay kit with increased sensitivity in relation toclinicopathologic features of solitary hepatocellular carcinomaHiroaki Okuda, Toshimi Nakanishi, Kazuko Takatsu, Akiko Saito, NaoakiHayashi, Ken Takasaki, Kazuyuki Takenami, Masakazu Yamamoto,Masayuki Nakano
544-549
LUNG (C34.9)Differential retinoblastoma and p16INK4A protein expression inneuroendocrine tumors of the lungHirotoshi Dosaka-Akita, Philip T. Cagle, Hiromitsu Hiroumi, MasahiroFujita, Motoyuki Yamashita, Anupama Sharma, Yoshikazu Kawakami,William F. Benedict
550-556
Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: APhase II studyRogerio Lilenbaum, Roberto Cano, Michael Schwartz, Leonard Siegel,Jose Lutzky, Mark Lewis, Elisa Krill, Luis Barreras, Enrique Davila
557-562
Lung carcinoma in 36 patients with human immunodeficiency virusinfectionUmberto Tirelli, Michele Spina, Simonetta Sandri, Diego Serraino, Carlo
563-569
Gobitti, Marco Fasan, Alessandro Sinicco, Pierluigi Garavelli, Anna LisaRidolfo, Emanuela VaccherBLOOD/BONE MARROW (C42.1)Expression of thrombopoietin and its receptor (c-mpl) in chronicmyelogenous leukemia: Correlation with disease progression and responseto therapyKerim Kaban, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, JorgeCortes, Francis J. Giles, Sherry Pierce, Maher Albitar
570-576
STOMACH (C42.2)Prognostic value of intratumoral natural killer cells in gastric carcinomaSumiya Ishigami, Shoji Natsugoe, Koki Tokuda, Akihiro Nakajo,Xiangming Che, Hirohumi Iwashige, Kuniaki Aridome, Shuichi Hokita,Takashi Aikou
577-583
SKIN (C44.9)A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in thetreatment of patients with advanced malignant melanomaLynn G. Feun, Niramol Savaraj, Judith Hurley, Angela Marini, ShenghanLai
584-588
Breslow thickness and Clark level in melanoma: Support for includinglevel in pathology reports and in American Joint Committee on CancerStagingAshfaq A. Marghoob, Karen Koenig, Flavia V. Bittencourt, Alfred W.Kopf, Robert S. Bart
589-595
BREAST (C50.9)Factors associated with local recurrence of mammographically detectedductal carcinoma in situ in patients given breast-conserving therapyLarry L. Kestin, Neal S. Goldstein, Mario D. Lacerna, MamthaBalasubramaniam, Alvaro A. Martinez, Murray Rebner, Jane Pettinga,Robert C. Frazier, Frank A. Vicini
596-607
Morbidity following sentinel lymph node biopsy versus axillary lymphnode dissection for patients with breast carcinomaPeter Schrenk, Roman Rieger, Andreas Shamiyeh, Wolfgang Wayand
608-614
PROSTATE (C61.9)Use of complementary health practices by prostate carcinoma patientsundergoing radiation therapyGary D. Kao, Pamela Devine
615-619
Acute myelogenous leukemia after exposure to strontium-89 for thetreatment of adenocarcinoma of the prostateSteven E. Kossman, Mark A. Weiss
620-624
URINARY BLADDER (C68.9)Flat intraepithelial lesions of the urinary bladderLiang Cheng, John C. Cheville, Roxann M. Neumann, David G. Bostwick
625-631
URINARY SYSTEM (C68.9)Inverted urothelial papilloma: Is ploidy, MIB-1 proliferative activity, orp53 protein accumulation predictive of urothelial carcinoma?John C. Cheville, Kevin Wu, Thomas J. Sebo, Liang Cheng, Darren
632-636
Riehle, Christine M. Lohse, V. Shane PankratzBRAIN (C71.9)Safety and efficacy of a multicenter study using intraarterial chemotherapyin conjunction with osmotic opening of the blood-brain barrier for thetreatment of patients with malignant brain tumorsNancy D. Doolittle, Michael E. Miner, Walter A. Hall, Tali Siegal, E.Jerome Hanson, Eva Osztie, Leslie D. McAllister, Joseph S. Bubalo, DaleF. Kraemer, David Fortin, Randal Nixon, Leslie L. Muldoon, Edward A.Neuwelt
637-647
HEAD AND NECK ( C76.0)Feasibility and early results of accelerated radiotherapy for head and neckcarcinoma in the elderlyAbdelkarim S. Allal, Daphné Maire, Minerva Becker, Pavel Dulguerov
648-652
GENERAL TOPICCANCER COMORBIDITYCancer and comorbidity: Redefining chronic diseasesKaren S. Ogle, G. Marie Swanson, Nancy Woods, Faouzi Azzouz
653-663
CANCER SCREENINGEarly findings from a community-based, cluster-randomized, controlledoral cancer screening trial in Kerala, IndiaRengaswamy Sankaranarayanan, Babu Mathew, Binu Jose Jacob, GigiThomas,Thara Somanathan, Paola Pisani, Manoj Pandey, KunnambathRamadas, K. Najeeb, Elizabeth Abraham
664-673
LIFE STYLE OF PATIENTS AFTER TREATMENT FOR CANCERCurrent health behaviors and readiness to pursue life-style changes amongmen and women diagnosed with early stage prostate and breast carcinomasWendy Demark-Wahnefried, Bercedis Peterson, Colleen McBride, IsaacLipkus, Elizabeth Clipp
674-684
PEDIATRIC ONCOLOGYRadiotherapy followed by high dose busulfan and thiotepa: A prospectiveassessment of high dose chemotherapy in children with diffuse pontinegliomasEric Bouffet, Marianne Raquin, Francois Doz, Jean-Claude Gentet,Chantal Rodary, Francois Demeocq, Pascal Chastagner, Patrick Lutz,Olivier Hartmann, Chantal Kalifa
685-692
Cerebral glucose metabolism in survivors of childhood acutelymphoblastic leukemiaMeri Kähkönen, Liisa Metsähonkala, Heikki Minn, Tapio Utriainen, TapioKorhonen, Marjá- Kaisu Norvasuo-Heilä-Saari,Tutula Äärima, HannaSuhanen-Polvi, Ulla Ruotsalaien, Olof Solin, and Toivo T. Salmi
693-700
QUALITY OF LIFEEvaluating the Quality of Cancer Care: Development of Cancer QualityIndicators for a Global Quality Assessment ToolJennifer L. Malin, Steven M. Asch , Eve A . Kerr, and Elizabeth A.McGlynn
701
CORRESPONDENCEHuman Immunodeficiency Virus Kaposi Sarcoma andLymphoproliferative Dosirders
708
VOL. 88, NO. 4; 15 FEBRUARY 2000REVIEW ARTICLEAdrenocortical carcinoma: Clinical and laboratory observationsBernardo Leo Wajchenberg, Maria A. Albergaria Pereira, Berenice B.Medonca, Ana C. Latronico, Paulo Campos Carneiro, Venancio A.Ferreira Alves, Maria Claudia N. Zerbini, Bernardo Liberman, GilbertoCarlos Gomes, Marvin A. Kirschner
711-736
ORIGINAL ARTICLEANATOMIC SITESTOMACH (C16.9)Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma:Results from a prospective study after 6.3 years of follow-upAnita A. M. Botterweck, Piet A. van den Brandt, R. Alexandra Goldbohm
737-748
SMALL INTESTINE (C17.9)Molecular identification of metastatic cancer to the skin using laser capturemicrodissection: A case reportSara Milchgrub, Ignacio I. Wistuba, Bong K. Kim, Cynthia Rutherford, JillUrban, Ponciano D. CruzJr., Adi F. Gazdar
749-754
COLON AND RECTUM (C19.9 )Adenomatous polyposis coli I1307K mutation in Jewish patients withdifferent ethnicity: Prevalence and phenotypeLiat Drucker, Ofer Shpilberg, Avivit Neumann, Jermey Shapira, RodicaStackievicz, Yoram Beyth, Shai Yarkoni
755-760
LIVER ( C22.0)Abnormal expression of hepatoma specific γ- glutamyl transferase andalteration of γ- glutamyl transferase gene methylation status in patientswith hepatocellular carcinomaDengfu Yao, Daorong Jiang, Zhongwei Huang, Jianxin Lu, Qiyuan Tao,Zhijian Yu, Xianyong Meng
761-769
GASTROINTESTINAL TRACT (C26.9)Treatment of carcinoid syndrome: A prospective crossover evaluation oflanreotide versus octreotide in terms of efficacy, patient acceptability, andtoleranceDermot O'Toole, Michel Ducreux, Gilles Bommelaer, Jean-LouisWemeau, Olivier Bouché, France Catus, Joëlle Blumberg, PhilippeRuszniewski
770-776
SOFT TISSUE (C49.9)Current follow-up strategies after potentially curative resection of 777-785
extremity sarcomas: Results of a survey of the members of the society ofsurgical oncologyAlan L. Beitler, Katherine S. Virgo, Frank E. Johnson, John F. Gibbs,William G. KraybillMenstrual and reproductive factors and risk of soft tissue sarcomasFrancesca Fioretti, Alessandra Tavani, Silvano Gallus, Eva Negri, SilviaFranceschi, Carlo LaVecchia
786-789
BREAST (C50.9)High dose chemotherapy and autologous blood stem cell support inwomen with breast carcinoma and isolated supraclavicular lymph nodemetastasesRick Abraham, Tracy Nagy, Paul E. Goss, Michael Crump
790-795
The predictive value of body protein for chemotherapy-induced toxicityAlireza Aslani, Ross C. Smith, Barry J. Allen, Nicholas Pavlakis, John A.Levi
796-803
The prognostic value of p53 and c-erb B-2 immunostaining is overratedfor patients with lymph node negative breast carcinoma: A multivariateanalysis of prognostic factors in 613 patients with a follow-up of 14-30yearsWenche Reed, Einar Hannisdal, Per Johannes Boehler, Stein Gundersen,Herman Host, Jahn Marthin Nesland
804-813
ENDOMETRIUM (C54.1)The frequency of p53, K-ras mutations, and microsatellite instabilitydiffers in uterine endometrioid and serous carcinoma: Evidence of distinctmolecular genetic pathwaysSigurd F. Lax, Brian Kendall, Hironori Tashiro, Robbert J. C. Slebos, LoraHedrick Ellenson
814-824
PROSTATE (C61.9)A randomized study comparing standard versus moderately high dosemegestrol acetate for patients with advanced prostate carcinoma: Cancerand leukemia Group B study 9181Nancy A. Dawson, Mark Conaway, Susan Halabi, Eric P. Winer, Eric J.Small, Diana Lake, Nicholas J. Vogelzang
825-834
KIDNEY (C64.9) 835-843Independent value of tumor size and DNA ploidy for the prediction ofdisease progression in patients with organ-confined renal cell carcinomaFranco Di Silverio, Paolo Casale, Dario Colella, Loreto Andrea, FulviaSeccareccia, Alessandro SciarraURINARY BLADDER (C67.9)Paraganglioma of the urinary bladder: Can biologic potential be predicted?Liang Cheng, Bradley C. Leibovich, John C. Cheville, Dharamdas M.Ramnani, Thomas J. Sebo, Roxann M. Neumann, Antonio G.Nascimento, Horst Zincke, David G. Bostwick
844-852
URINARY SYSTEM (C68.9)Atypical nephrogenic metaplasia of the urinary tract: A precursor lesion?Liang Cheng, John C. Cheville, Thomas J. Sebo, John N. Eble, David G.
853-861
BostwickBRAIN (C71.9)Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World HealthOrganization Grade 2 oligodendrogliomaJorge S. Reis-Filho, Leonardo N. Faoro, Carla Carrilho, Luiz F. Bleggi-Torres, Fernando C. Schmitt
862-869
Stereotactic radiosurgery for recurrent ependymomaScott L. Stafford, Bruce E. Pollock, Robert L. Foote, Deborah A. Gorman,Diana F. Nelson, Paula J. Schomberg
870-875
HEAD AND NECK (C76.0)Mature results of a Phase III randomized trial comparing concurrentchemoradiotherapy with radiation therapy alone in patients with Stage IIIand IV squamous cell carcinoma of the head and neckDavid J. Adelstein, Pierre Lavertu, Jerrold P. Saxton, Michelle Secic,Benjamin G. Wood, John R. Wanamaker, Isaac Eliachar, Marshall Strome,Marjorie A. Larto
876-883
The origins of multiple squamous cell carcinomas in the aerodigestive tractMonique G. C. T. van Oijen, Fredriek G. J. Leppers vd Straat, Marcel G. J.Tilanus, Pieter J. Slootweg
884-893
LYMPH NODE (C77.9)Bone marrow staging of patients with non-Hodgkin lymphoma by flowcytometry: Correlation with morphologyPeter R. Duggan, David Easton, Joanne Luider, Iwona A. Auer
894-899
GENERAL TOPICPALLIATIVE CAREAssessment of the need for palliative care as perceived by individualcancer patients and their families: A review of instruments for improvingpatient participation in palliative careBart H. P. Osse, Myrra J. F. J. Vernooij-Dassen, Berna P. W. de Vree,Egbert Schadé, Richard P. T. M. Grol
900-911
COMMUNICATIONThe American College of Surgerons Commision on Cancer and theAmerican Cancer SocietyThe National Cancer Data Base report on treatment patterns forhepatocellular carcinomas: Improved survival of surgically resectedpatients, 1985-1996William G. Cance, Andrew K. Stewart, Herman R. Menck
912-920
The National Cancer Data Base report on poor survival of U.S. gastriccarcinoma patients treated with gastrectomy: Fifth edition American JointCommittee on Cancer staging, proximal disease, and the “differentdisease” hypothesisScott A. Hundahl, Jerri Linn Phillips, Herman R. Menck
921-932
National Cancer Data Base survey of breast cancer management forpatients from low income zip codesLaMar S. McGinnis, Herman R. Menck, Harmon J. Eyre, Kirby I. Bland,
933-945
Carol E. H. Scott-Conner, Monica Morrow, David P. WinchesterCONCENSUS CONFERENCE ON THE CLASSIFICATION OFDUCTAL CARCINOMA OF THE BREAST, APRIL 22-25, 1999Consensus Conference on the treatment of in situ ductal carcinoma of thebreast, April 22-25, 1999Gordon F. Schwartz, Lawrence J. Solin, Ivo A. Olivotto, Virginia L.Ernster, Peter I. Pressman
946-954
INTERNATIONAL UNION AGAINTS CANCER (UICC)Report on Prostate Cancer Tumor Marker Workshop 1999Alan W. Partin, Gerald P. Murphy, Michael K. Brawer
955-963
CORRESPONDENCEMultiple chondromatous hamartomas of the lung: A case report andreview of the literature with special reference to Carney syndromeuayib Yalçin, Aye Kars
964
Trilateral retinoblastoma: Is the location of the intracranial tumorimportant?Annette C. Moll, Saskia M. Imhof, Antoinette Y. N. Schouten-vanMeeteren, Maarten Boers
965-966
VOL. 88, NO: 5; 1 MARCH 2000TRIBUTEGerald P. Murphy, M.D., D.Sc.: In memoriamRobert V. P. Hutter
fmxx
EDITORIALDiscrepancies between east and westJeremy R. Jass
969-970
Pathologic analysis of sentinel lymph nodes in breast carcinomaLaura Liberman
971-977
EDITORIAL COUNTERPOINTDespite limited data, coexistent lobular carcinoma in situ should not be acontraindication to breast conservation for women with invasive breastcarcinomaHarry D. Bear, W. Hans Carter Jr., Margaret M. Grimes
978-981
REPLY TO COUNTERPOINTDespite limited data, coexistent lobular carcinoma in situ should not be acontraindication to breast conservation for women with invasive breastcarcinoma: ReplyAnthony L. Abner
982-983
ORIGINAL ARTICLEANATOMICSALIVARY GLAND (C08.9)Salivary flow and its relation with oral symptoms in terminally III patientsGavriel Chaushu, Michaela Bercovici, Shay Dori, Alexander Waller,Shlomo Taicher, Jona Kronenberg, Yoav P. Talmi
984-987
ESOPHAGUS (C15.9)A Phase I/II study of external beam radiation, brachytherapy, andconcurrent chemotherapy for patients with localized carcinoma of the
988-995
esophagus (Radiation Therapy Oncology Group study 9207): Final reportLaurie E. Gaspar, Kathryn Winter, Walter I. Kocha, Lawrence R. Coia,Arnold Herskovic, Mary GrahamDifferences in diagnostic criteria for esophageal squamous cell carcinomabetween Japanese and Western pathologistsRonald J. Schlemper, Sanford M. Dawsey, Masayuki Itabashi, AkinoriIwashita, Yo Kato, Morio Koike, Klaus J. Lewin, Robert H. Riddell,Tadakazu Shimoda, Pentti Sipponen, Manfred Stolte, Hidenobu Watanabe
996-1006
COLON AND RECTUM (C19.9)Preoperative treatment with tegafur suppositories enhances apoptosis andreduces the intratumoral microvessel density of human colorectalcarcinomaTakahiko Matsuura, Yasuhiko Fukuda, Tsuruo Fujitaka, TakashiNishisaka,Takashi Sakatani, Hisao Ito
1007-1015
LIVER (C22.0)Effect of viral status on recurrence after liver resection for patients withhepatitis B virus-related hepatocellular carcinomaShoji Kubo, Kazuhiro Hirohashi, Hiromu Tanaka, Tadashi Tsukamoto,Taichi Shuto, Takatsugu Yamamoto, Takashi Ikebe, Kenichi Wakasa,Shuhei Nishiguchi, Hiroaki Kinoshita
1016-1024
Lack of frameshift mutations at coding mononucleotide repeats inhepatocellular carcinoma in Japanese patientsAyuko Saeki, Shinji Tamura, Nobuyuki Ito, Shinichi Kiso, YasuoMatsuda, Iwao Yabuuchi, Sumio Kawata, Yuji Matsuzawa
1025-1029
p53 mutation pattern in hepatocellular carcinoma in workers exposed tovinyl chlorideMarkus Weihrauch, Gerhard Lehnert, Ferdinand Köckerling, ChristianWittekind, Andrea Tannapfel
1030-1036
PANCREAS (C25.9)Molecular detection of metastatic pancreatic carcinoma cells using amultimarker reverse transcriptase-polymerase chain reaction assayAnton Bilchik, Miki Miyashiro, Mark Kelley, Christine Kuo, YoshiyukiFujiwara, Shogi Nakamori, Morito Monden, Dave S. B. Hoon
1037-1044
LUNG (C34.9)Phase I trial of docetaxel and vinorelbine in patients with advancednonsmall cell lung carcinomaVincent A. Miller, Kenneth K. Ng, Lee M. Krug, Wendy Perez, BarbaraPizzo, Robert T. Heelan, Mark G. Kris
1045-1050
MEDIASTINUM (C38.3)Results of modern therapy for patients with mediastinal nonseminomatousgerm cell tumorsKristen N. Ganjoo, Karen M. Rieger, Kenneth A. Kesler, Matt Sharma,Douglas K. Heilman, Lawrence H. Einhorn
1051-1056
BLOOD/BONE MARROW (C42.1)ATM gene deletion in patients with adult acute lymphoblastic leukemiaMohammad A. Haidar, Hagop Kantarjian, Taghi Manshouri, Chin-Yung
1057-1062
Chang, Susan O'Brien, Emil Freireich, Michael Keating, Maher AlbitarSKIN (44.9)Analysis of prognosis and disease progression after local recurrence ofmelanomaXiang D. Dong, Douglas Tyler, Jeffrey L. Johnson, Pierre DeMatos,Hilliard F. Seigler
1063-1071
BREAST (C50.9)The relation between the presence and extent of lobular carcinoma in situand the risk of local recurrence for patients with infiltrating carcinoma ofthe breast treated with conservative surgery and radiation therapyAnthony L. Abner, James L. Connolly, Abram Recht, Bruce Bornstein,Asa Nixon, Stella Hetelekidis, Barbara Silver, Jay R. Harris, Stuart J.Schnitt
1072-1077
Cutaneous fibrosis induced by docetaxel: A case reportMark G. Cleveland, B. S. Ajaikumar, Rohini Reganti
1078-1081
Pamidronate prevents skeletal complications and is effective palliativetreatment in women with breast carcinoma and osteolytic bone metastases:Long term follow-up of two randomized, placebo-controlled trialsAllan Lipton, Richard L. Theriault, Gabriel N. Hortobagyi, JosephSimeone, Robert D. Knight, Kathleen Mellars, Dirk J. Reitsma, MaikaHeffernan, John J. Seaman
1082-1090
Mutant p53 protein overexpression in women with ipsilateral breast tumorrecurrence following lumpectomy and radiation therapyBruce C. Turner, Andrew A. Gumbs, Christopher J. Carbone, DarrylCarter, Peter M. Glazer, Bruce G. Haffty
1091-1098
Pathologic analysis of sentinel and nonsentinel lymph nodes in breastcarcinoma: A multicenter studyDonald L. Weaver, David N. Krag, Takamaru Ashikaga, Seth P. Harlow,Maureen O'Connell
1099-1107
CERVIX (C53.9)Expression of MN/CA9 Protein in Papanicolaou Smears ContainingAtypical Glandular Cells of Undetermined Significance Is a DiagnosticBiomarker of Cervical Dysplasia and NeoplasiaShu-Yuan Liao and Eric J. Stanbridge
1108
PROSTATE (C61.9)Primary Treatment Choices for Men with Clinically Localized ProstateCarcinoma Detected by ScreeningYan Yan, Gustavo F Carvalhal, William J. Catalona, and James D. Young
1122
BLADDER (C67.9)Expression of Thymidine Phosphorylase as an Indicator of Poor Prognosisfor Patients with Transitional Cell Carcinoma of the BladderJun-ichirou Aiima, Yoshiharu Imazono, Yuji Takebayashi, KenryuNishiyama, Tsutomu Shirahama, Suminori Akiba, Tatsuhiko Furukawa,Shin-ichi Akiyama, and Yoshitada Ohi
1131
THYROID (C73.9)Medullary Thyroid Carcinoma: Clinical Characteristics, Treatment, 1139
Prognostic Factors, and a Comparison of Staging SystemsElectron Kebebew, Philip H. G. Ituarte, Allan E. Siperstein, Quan-YangDuh, and Orlo H. ClarkPrimary Thyroid Teratomas: A Clinicopathologic Study of 30 CasesLester D. R. Thompson, Juan Rosai, and Clara S. Heffess
1149
ADRENAL GLAND (C74.9)Phase II Evaluation of Cisplatin and Etoposide Followed by Mitotane atDisease Progression in Patients with Locally Advanced or MetastaticAdrenocortical Carcinoma: A Southwest Oncology Group StudyStephen K. Williamson, Danika Lew, Gary J. Miller, Stanley P. Balcerzak,Laurence H. Baker, and E. David Crawford
1159
GENERAL TOPICPEDIATRIC ONCOLOGYAlternating Drug Pairs with or without Periodic Reinduction in Childrenwith Acute Lymphoblastic Leukemia in Second Bone Marrow Remission:A Pediatric Oncology Group StudyGeorge R. Buchanan, Gaston K. Rivera, Brad H. Pollock, James M.Boyett, Allen R. Chauvenet, Hans Wagner, David A. Maybee, William M.Crist, and Donald Pinkel
1166
Symptom and Quality of Life Survey of Medical Oncology Patients at aVeterans Affairs Medical Center: A Role for Symptom AssessmentVictor T. Chang, Shirley S. Hwang, Martin Feuerman, and Basil S.Kasimis
1175
CORRESPONDENCEPretreatment Staging by Endoscopic Ultrasonography Does Not PredictComplete Response to Neoadjuvant Chemoradiation in Patients withEsophageal Carcinoma
1184
VOL. 88, SUPLEMENTO 5; 1 MARCH 2000Acknowledgments,Workshop Plannig Committe Roster, Etiology WorkingGroup Roster, and Workshop Participants
vii
Introduction to the workshopDoris Browne, A. Patricia Romilly-Harper
1187-1188
KEYNOTE ADDRESSA conceptual framework for the planning of ethno-oncologyM. Alfred Haynes
1189-1192
WORKGROUP PRESENTATIONSEpidemiology, stage at diagnosis, and tumor biology of breast carcinomain multiracial and multiethnic populationsCarrie P. Hunter
1193-1202
Migration patterns and breast carcinomaJudith Salmon Kaur
1203-1206
Urban Native American health issuesLinda Burhansstipanov
1207-1213
Changing the research paradigm: Community involvement in population-based researchNgina Lythcott
1214-1216
The excess burden of breast carcinoma in minority and medicallyunderserved communities: Application, research, and redressinginstitutional racismSusan M. Shinagawa
1217-1223
Ongoing research to identify environmental risk factors in breastcarcinomaMarian C. Johnson-Thompson, Janet Guthrie
1224-1229
Breast carcinoma etiology: Current knowledge and new insights into theeffects of reproductive and hormonal risk factors in black and whitepopulationsDorothy R. Pathak, Janet R. Osuch, Jianping He
1230-1238
Diet and breast carcinoma in multiethnic populationsAnna H. Wu
1239-1244
Dietary and/or nutritional risk factors and breast carcinoma: ConsumerresponseJackie Young
1245-1247
Associations between energy balance and body mass index and risk ofbreast carcinoma in women from diverse racial and ethnic backgrounds inthe U.S.Anne McTiernan
1248-1255
Socioeconomic factors and breast carcinoma in multicultural womenClaudia R. Baquet, Patricia Commiskey
1256-1264
Multicultural aspects of breast cancer etiology workshop: ConcludingcommentsJames N. Ingle
1265-1266
Abstracts of poster presentations 1267-1271Recommendations of the workshopDoris Browne, A. PatriciaRomilly-Harper
1272-1276
VOL. 88, NO. 7; 1 APRIL 2000EDITORIAL COUNTERPOINTWorld Health Organization and International Society of UrologicalPathology classification and two-number grading system of bladder tumorsRyoichi Oyasu
1509-1512
REPLY TO COUNTERPOINTWorld Health Organization and International Society of UrologicalPathology Classification and two-number grading system of bladdertumors: replyLiang Cheng, David G. Bostwick
1513-1516
REVIEW ARTICLESurgery versus radiation therapy for patients with aggressive fibromatosisor desmoid tumors: A comparative review of 22 articlesJoost J. Nuyttens, Philip F. Rust, Charles R. Thomas Jr., Andrew T. TurrisiIII
1517-1523
ORIGINAL ARTICLEANATOMIC SITEESOPHAGUS (C15.9)
Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagusKazuo , Koyanagi , Soji Ozawa, Nobutoshi Ando, Makio Mukai, YukoKitagawa, Masakazu Ueda, Masaki Kitajima
1524-1529
STOMACH (C16.9)Assessment of gastric carcinoma risk associated with Helicobacter pylorimay vary depending on the antigen used: CagA specific enzyme-linkedimmunoadsorbent assay (ELISA) versus commercially available H. pyloriELISAsShin Maeda, Haruhiko Yoshida, Keiji Ogura, Yutaka Yamaji, TsuneoIkenoue, Toru Mitsushima, Hitoshi Tagawa, Ryuji Kawaguchi, KiyoshiMori, Ken-ichi Mafune, Takao Kawabe, Yasushi Shiratori, Masao Omata
1530-1535
COLON AND RECTUM (C19.9)Thomsen-Friedenreich antigen presents as a prognostic factor in colorectalcarcinoma: A clinicopathologic study of 264 patientsStephan E. Baldus, Thomas K. Zirbes, Franz-Georg Hanisch, DoreenKunze, Sven T. Shafizadeh, Silke Nolden, Stefan P. Mönig, Paul M.Schneider, Uwe Karsten, Juergen Thiele, Arnulf H. Hölscher, Hans P.Dienes
1536-1543
Prognostic influence of tumor-associated eosinophilic infiltrate incolorectal carcinomaM. J. Fernández-Aceñero, M. Galindo-Gallego, J. Sanz, A. Aljama
1544-1548
Limited but definite efficacy of prophylactic hepatic arterial infusionchemotherapy after curative resection of colorectal liver metastases: Arandomized studyTakeshi Tono, Yasunori Hasuike, Hiroki Ohzato, Yuichi Takatsuka,Nobuteru Kikkawa
1549-1556
LIVER (C22.0)Unique clinical characteristics of patients with hepatocellular carcinomawho present with high plasma des-γ-carboxy prothrombin and low serum -α fetoproteinKeisuke Hamamura, Yasushi Shiratori, Shuichiro Shiina, MasatoshiImamura, Shuntaro Obi, Shinpei Sato, Haruhiko Yoshida, Masao Omata
1557-1564
p53 tumor suppressor gene mutations in hepatocellular carcinoma patientsin indiaSanjay Katiyar, Bipin C. Dash, Varsha Thakur, Raj C. Guptan, Shiv K.Sarin, Bhudev C. Das
1565-1573
Transcatheter arterial chemoembolization therapy using iodized oil forpatients with unresectable hepatocellular carcinoma: Evaluation of threekinds of regimens and analysis of prognostic factorsKazuto Ueno, Nobuaki Miyazono, Hiroki Inoue, Hirotoshi Nishida, IchiroKanetsuki, Masayuki Nakajo
1574-1581
PANCREAS (C25.9)Hepatoid carcinoma of the pancreasGladell P. Paner, Karen S. Thompson, Cesar V. Reyes
1582-1589
LUNG (C34.9)
Atypical bronchopulmonary carcinoids show a tendency toward increasedapoptotic and proliferative activityKatja L. J. Laitinen, Ylermi Soini, Jorma Mattila, Paavo Pääkkö
1590-1598
BLOOD/BONE MARROW (C42.1)Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for thediagnosis of central nervous system involvement in hematooncologicpatientsIzidore S. Lossos, Raphael Breuer, Orna Intrator, Alexander Lossos
1599-1604
SKIN (C44.9)Perineural spread of basal cell carcinomas treated with mohs micrographicsurgeryDésirée Ratner, Lori Lowe, Timothy M. Johnson, Darrell J. Fader
1605-1613
SOFT TISSUE (C49.9)Growth inhibitory effects of paclitaxel on human epithelioid sarcoma invitro: Heterogeneity of response and the multidrug resistance phenotypePetra Reinecke, Christiane Knopf, Michael Schmitz, Eva M. Schneider,Helmut E. Gabbert, Claus D. Gerharz
1614-1622
BREAST (C50.9)Clinical implication of altered expression of Mad1 protein in human breastcarcinomaSehwan Han, Kyeongmee Park, Hong-Yong Kim, Myung-Soo Lee, Hong-Joo Kim, Young-Duck Kim, Young Jin Yuh, Sung Rok Kim, Hyun SukSuh
1623-1632
Primary axillary radiotherapy as axillary treatment in breast-conservingtherapy for patients with breast carcinoma and clinically negative axillarylymph nodesFrank J. P. Hoebers, Jacques H. Borger, Augustinus A. M. Hart, JohannesL. Peterse, Emiel J. Th.Rutgers, Joos V. Lebesque
1633-1642
Outcomes and factors impacting local recurrence of ductal carcinoma insituElaine Y. Weng, Guy J. F. Juillard, Robert G. Parker, Helena R. Chang,Jeffrey A. Gornbein
1643-1649
CERVIX (53.9)Human tumor growth is inhibited by a vaccinia virus carrying the E2 geneof bovine papillomavirusViviana Valadez Graham, Gerd Sutter, Marco V. José, Alejandro García-Carranca, Volker Erfle, Norma Moreno Mendoza, Horacio Merchant,Ricardo Rosales
1650-1662
BLADDER (C67.9)Cancer heterogeneity and its biologic implications in the grading ofurothelial carcinomaLiang Cheng, Roxann M. Neumann, Ajay Nehra, Bruce E. Spotts, Amy L.Weaver, David G. Bostwick
1663-1670
URINARY SYSTEM (C68.9)Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitionalcell carcinoma of the urothelial tract: Final report of a phase II trial
1671-1678
evaluating two dosing schedulesDean F. Bajorin, John A. McCaffrey, Paul M. Dodd, Susan Hilton, MadhuMazumdar, W. Kevin Kelly, Harry Herr, Howard I. Scher, EvelynIcasiano, Geralyn HigginsSquamous papilloma of the urinary tract is unrelated to condylomaacuminataLiang Cheng, Bradley C. Leibovich, John C. Cheville, Dharamdas M.Ramnani, Thomas J. Sebo, Ajay Nehra, Reza S. Malek, Horst Zincke,David G. Bostwick
1679-1686
GENERAL TOPICFOLLOW-UP OF PATIENTS TREATED FOR CANCERGrading of late effects in young adult survivors of childhood cancerfollowed in an ambulatory adult settingKevin C. Oeffinger, Debra A. Eshelman, Gail E. Tomlinson, George R.Buchanan, Barbara M. Foster
1687-1695
HIV-RELATED NON-HODGKIN LYMPHOMAPrognostic factors after non-Hodgkin lymphoma in patients infected withthe human immunodeficiency virus: Aquitaine cohort, France, 1986-1997Frantz Thiessard, Philippe Morlat, Catherine Marimoutou, Eric Labouyrie,Jean-Marie Ragnaud, Jean-Luc Pellegrin, Michel Dupon, François Dabis
1696-1702
METASTATIC MELANOMA: PHASE II CLINICAL TRIALA phase II study of “decrescendo” interleukin-2 plus interferon-α-2a inpatients with progressive metastatic melanoma after chemotherapyOmar Eton, Antonio C.Buzaid, Agop Y. Bedikian, Teresa M. Smith,Nicholas E. Papadopoulos, Julie A. Ellerhorst, Janelle L. Hibberts, SewaS. Legha, Robert S. Benjamin
1703-1709
PEDIATRIC ONCOLOGYFeasibility of oral ciprofloxacin for the outpatient management of febrileneutropenia in selected children with cancerVictor M.Aquino, Larry Herrera, Eric S. Sandler, George R. Buchanan
1710-1714
QUALITY OF LIFEMeasuring quality of life of chinese cancer patients: A validation of theChinese version of the Functional Assessment of Cancer Therapy-general(FACT-G) scaleClara L. M. Yu, Richard Fielding, Cecelia L. W. Chan, Vincent K. C. Tse,Peter H. K. Choi, W. H. Lau, Damon T. K. Choy, S. K. O, Anne W. M.Lee, Jonathan S. T. Sham
1715-1727
UPPER AERODIGESTIVE TRACTCancers of the upper aerodigestive tract in Ontario, Canada, and theUnited StatesDavid P. Skarsgard, Patti A. Groome, William J. Mackillop, Sam Zhou,Deanna Rothwell, Peter F. Dixon, Brian O'Sullivan, Steven F. Hall, Eric J.Holowaty
1728-1738
COMMUNICATIONAMERICAN JOINT COMMITTE ON CANCERAmerican Joint Committee on Cancer prognostic factors consensus 1739-1757
conference: Colorectal working groupCarolyn Compton, Cecilia M. Fenoglio-Preiser, Norman Pettigrew, L.Peter FieldingCORRESPONDENCEThe natural history of breast carcinoma: What have we learned fromscreening?Thomas J. Anderson, Freda E. Alexander, Patrick M. Forrest
1758-1759
Determining the site of the primary cancer in patients with skeletalmetastasis of unknown origin: A retrospective studyJean Francis Maillefert, Christian Tavernier, Jacques Tebib
1759-1760
Top Related